July 14, 2022 20:30 UTC Labcorp, a leading global life sciences company, announced that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022, to stockholders of record as of the close of business on August 18, 2022.
About Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220714005817/en/
Investors: Chas Cook - 336-436-5076
Investor@Labcorp.com
Media: Christopher Allman-Bradshaw - 336-436-8263
Media@Labcorp.com
Source: Labcorp
View this news release online at:
http://www.businesswire.com/news/home/20220714005817/en
